Rhumbline Advisers Boosts Stock Holdings in Summit Therapeutics Inc. (NASDAQ:SMMT)
Rhumbline Advisers raised its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 4.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 125,202 shares of the company’s stock after acquiring an additional 5,394 shares during the quarter. Rhumbline Advisers’ holdings […]
Rhumbline Advisers raised its holdings in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 4.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 125,202 shares of the company’s stock after acquiring an additional 5,394 shares during the quarter. Rhumbline Advisers’ holdings […]
